More than 1,400 workers in West Virginia are set to lose their jobs this week when the Viatris pharmaceuticals plant in Morgantown shuts down and moves operations overseas to India and Australia. Workers say they’ve had no response to their urgent requests for help from their Democratic senator, Joe Manchin, who is often called the most powerful man in Washington. Viatris was formed through a merger between two pharmaceutical companies, Mylan and Upjohn. Mylan’s chief executive, Manchin’s daughter Heather Bresch, got a $31 million payout as a result of the corporate consolidation before the new company set about cutting costs, including the closure of the Morgantown plant. Joseph Gouzd, president of United Steelworkers of America Local 8-957 and a worker at the plant, says Viatris has given little reason for the closure except to say the company is looking to “maximize the best interests of the shareholders.” We also speak with investigative journalist Katherine Eban, who says moving pharmaceutical production overseas contradicts the recommendations of numerous reports that have found major safety lapses in drug manufacturing abroad, as well as concern from lawmakers about keeping a key industry within the United States. “This is pure insanity,” Eban says. “It seems like it is both pharmaceutical and national security suicide to close this plant.”